- Home
- PBYI vs PFL Comparison
PBYI vs PFL Comparison
Compare PBYI & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | PFL |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.9M | 371.7M |
| IPO Year | 2011 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PBYI | PFL |
|---|---|---|
| Price | $6.97 | $8.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 242.9K | ★ 270.0K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.69 | $7.60 |
| 52 Week High | $7.68 | $8.70 |
Technical Indicators
Market Signals| Indicator | PBYI | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 52.66 |
| Support Level | $6.21 | $7.60 |
| Resistance Level | $7.25 | $8.49 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | 0.12 | 0.04 |
| Stochastic Oscillator | 95.24 | 96.15 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.